| Name | Title | Contact Details |
|---|
Peer Point Medical Education Institute is a Evanston, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
At PreferredOne, our name says it all. You, our valued members, are our preferred ones. Everything we do is for one purpose - to make your experience the best it can be. We offer individual health insurance, family medical plans and group health insurance to fit your needs and budget, plus wellness programs to help you stay healthy. We are known for outstanding customer service and for paying claims promptly, and our representatives are available to answer any questions you have about health care coverage. PreferredOne has served our Minnesota and upper Midwest members for almost 30 years.
Ideomed is a Grand Rapids, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
AcelRx Pharmaceuticals Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of moderate-to-severe acute pain. The Company`s product candidates, DSUVIA™ (known as ARX-04 outside of the United States) and ZALVISO®, are designed to deliver sufentanil, a strong opioid analgesic, via a non-invasive, sublingual formulation in medical supervised settings. DSUVIA is designed to deliver sublingual tablets containing 30 mcg sufentanil via a disposable, pre-filled, single-dose applicator. The Phase 3 clinical program has completed and assessed the investigational product in the treatment of moderate-to-severe acute pain in patients who had undergone surgery or who presented to an emergency room with trauma or injury. In clinical studies, DSUVIA demonstrated reductions in pain intensity as early as 15-to-30 minutes after the start of dosing and the most common adverse events included nausea, headache, dizziness, and vomiting. A New Drug Application (NDA) was filed with the FDA in December 2016. ZALVISO is designed to deliver sublingual tablets containing 15 mcg sufentanil via a novel hand-held, pre-programmed, patient-controlled analgesia system. Three Phase 3 clinical trials have been completed in patients who had undergone major abdominal or orthopedic surgeries. A fourth study (IAP312) is underway to further evaluate the overall performance of the ZALVISO System in post-surgical patients. ZALVISO is currently approved by the European Commission for the management of acute moderate-to-severe post-operative pain in adult patients in a hospital setting, and is marketed by Grünenthal Group, AcelRx`s licensee in Europe and Australia. In the United States and other geographies, ZALVISO remains an investigational product.
Always There Resources is a Glen Ellyn, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.